Skip to content
AEFA - Standing Committee

Foreign Affairs and International Trade

Witnesses

Information prior to the 40th Parliament is from notices of meetings. For the official record, please refer to the related minutes and transcripts. There are limited electronic records available for the period prior to the 35th Parliament. For historical information, please contact: ctm@sen.parl.gc.ca or 1-800-267-7362


Organization Activate to sort column ascending Activate to sort column descending Name / Title Activate to sort column ascending Activate to sort column descending Study/Bill Activate to sort column ascending Activate to sort column descending Date/Time Activate to sort column ascending Links/Notes
Foreign Affairs and International Trade Canada Christopher Armstrong, Senior Advisor, HIV/AIDS, Human Rights, Humanitarian Affairs and International Women's Equality Division Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Industry Canada Susan Bincoletto, Acting Director General, Marketplace Framework Policy Branch Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Canadian International Development Agency Sandra Black, Director, Social Development Policies, Policy Branch Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Canada's Research-Based Pharmaceutical Companies Adrienne Blanchard, Legal Counsel, Gowling, Lafleur and Henderson Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Industry Canada Doug Clark, Senior Project Leader, Patent Policy Directorate Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Industry Canada Éric Dagenais, Director, Patent Policy Directorate Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
The Honourable Bill Graham, P.C., M.P., Minister of Foreign Affairs Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Canadian Generic Pharmaceutical Association Jim Keon, President Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Health Canada David K. Lee, Directorate, Office of Patented Medicines and Liaison, Therapeutic Products Directorate, Health Products and Food Branch Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Canada's Research-Based Pharmaceutical Companies Jean-François Leprince, President, Aventis Pharmaceutical, Chair, Rx&D Intellectual Property Committee Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act May 12, 2004
Back to top